Agilent Technologies Acquires e-MSion
March 9, 2023
Agilent Technologies has acquired e-MSion, the early-stage company behind the ExD cell electron capture dissociation (ECD) technology for benchtop mass spectrometers. The purchase brings e-MSion's ExD cell and associated tools into Agilent's life-sciences instrument portfolio to expand biopharma characterization capabilities and make ECD accessible to a broader set of labs.
- Buyers
- Agilent Technologies
- Targets
- e-MSion
- Industry
- Medical Devices
- Location
- Oregon, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Experity Acquires Exdion Healthcare
July 1, 2026
Cloud & SaaS
Experity acquired Exdion Healthcare, an AI-driven SaaS company focused on automating the patient chart-to-cash revenue cycle workflow (coding, billing, compliance, and revenue cycle automation). The acquisition is intended to unify clinical, operational, and financial workflows with AI to accelerate reimbursement, reduce manual work, and minimize denials; financial terms were not disclosed. Exdion’s insurance-focused affiliate was excluded from the transaction and will continue to operate independently.
-
VION Biosciences Acquires Echelon Biosciences
August 22, 2024
Biotechnology
VION Biosciences, the life-science platform backed by Iron Path Capital, has acquired Salt Lake City-based Echelon Biosciences, a specialist supplier of lipid-based excipients and lipid nanoparticles. The add-on strengthens VION's capabilities in lipid synthesis and lipid nanoparticle technology to support mRNA and gene-therapy development and advances the platform toward drug manufacturing while keeping Echelon’s leadership and operations intact.
-
Bruker Corporation Acquires Nion
January 3, 2024
Manufacturing
Bruker Corporation has acquired Nion, a Kirkland, Washington developer and manufacturer of high-end scanning transmission electron microscopes (STEM), including the UltraSTEM line and advanced EELS technology. The acquisition strengthens Bruker's materials science instrumentation portfolio and provides capabilities for electron diffraction crystallography; Nion reported approximately $8 million in revenue in 2023. Financial terms were not disclosed.
-
Cell Microsystems Acquires Fluxion Biosciences
August 23, 2023
Medical Devices
Durham-based Cell Microsystems has acquired Fluxion Biosciences, adding Fluxion's IonFlux, BioFlux and IsoFlux instruments and services to its CellRaft-based product portfolio. The deal is supported by a concurrent Series B financing led by Telegraph Hill Partners to provide growth capital and accelerate product and service integration for cellular analysis and electrophysiology workflows.
-
Summa Equity Acquires Majority Stake in Axion BioSystems
July 15, 2021
Medical Devices
Summa Equity Fund II has acquired a majority stake in Axion BioSystems, a US life science tools company that develops MEA (microelectrode array) and impedance-based bioelectronic assay technologies. Summa plans to support Axion's commercial scale-up and global growth to accelerate adoption of its platforms across academia and biopharma, particularly in cell and gene therapy and drug discovery applications.
-
MHC Software Acquires Ecrion Software
June 22, 2020
Software
MHC Software has acquired Ecrion Software, a Rockville-based provider of customer communication management (CCM) and customer experience automation (CXA) software and services. The deal adds omnichannel communication, dynamic documents, and customer journey automation capabilities to MHC's enterprise automation platform and follows a prior majority investment in MHC by Strattam Capital.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.